BioNote, Inc. (KRX:377740)
South Korea
· Delayed Price · Currency is KRW 5,060.00
-10.00 (-0.20%)
At close: Jun 27, 2025, 3:30 PM KST
BioNote Market Cap
BioNote has a market cap or net worth of 526.06 billion as of June 27, 2025. Its market cap has increased by 26.19% in one year.
Market Cap
526.06B
Enterprise Value
141.88B
Revenue
105.92B
Ranking
n/a
PE Ratio
12.47
Stock Price
5,060.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 526.06B, a decrease of -51.51%. That is a compound annual growth rate of -25.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 512.89B | 6.70% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.46T |
| Celltrion | 35.49T |
| ALTEOGEN | 20.84T |
| Yuhan | 7,589.05B |
| SK Biopharmaceuticals | 7,236.14B |
| HLB Co., Ltd. | 6,512.41B |
| PharmaResearch | 4,992.23B |
| Peptron | 4,741.01B |